Henderson A R
J Clin Pathol. 1982 Sep;35(9):986-98. doi: 10.1136/jcp.35.9.986.
The requirements for a clinical biochemistry test request form are reviewed. The interaction between the configuration of the main analysers and the number of individual tests, or profiles, that are ordered using different request form formats were monitored for three-month periods over a three-year period while the main analysers were being "reconfigured" or replaced. Although there was a significant increase in orders for individual tests (compared to profile requests) required on outpatients this did not occur with the inpatient ordering pattern. Instead, the numbers of discretionary tests dropped and more miniprofiles--for example, the electrolyte group, were ordered, although the total number of profiles (per patient day) did not increase because the "electrolyte-urea-creatinine" profile numbers markedly decreased during rhe period of the study. This shift in ordering patterns was assumed to be due to the faster turnaround of "priority" (emergency) test requests which could, due to improved instrumentation, be analysed as quickly as individual test requests. Glucose was dropped from the major profile and the numbers of discretionary glucose requests did not increase. It was concluded that, providing this single test can be performed efficiently, there is no need for glucose to be included in test profiles.
对临床生物化学检验申请单的要求进行了审查。在三年期间,当主要分析仪进行“重新配置”或更换时,对主要分析仪的配置与使用不同申请单格式所订购的单项检验或组合检验数量之间的相互作用进行了为期三个月的监测。尽管门诊患者所需单项检验(与组合检验申请相比)的订单显著增加,但住院患者的订购模式并未出现这种情况。相反,自选检验的数量下降,更多的小型组合检验——例如电解质组被订购,尽管(每日每位患者的)组合检验总数没有增加,因为在研究期间“电解质-尿素-肌酐”组合检验的数量显著减少。订购模式的这种转变被认为是由于“优先”(急诊)检验申请的周转速度加快,由于仪器改进,其分析速度可与单项检验申请一样快。葡萄糖从主要组合检验中剔除,自选葡萄糖检验的数量没有增加。得出的结论是,如果能够高效地进行这种单项检验,则无需将葡萄糖纳入检验组合。